The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK regulator responsible for medicines, medical devices, and clinical trial oversight.
MHRA requirements influence clinical trial authorization, safety reporting, and compliance expectations for studies conducted in the UK. For multinational trials, sponsors often align documentation and safety governance to satisfy both MHRA and other regulators such as FDA and EMA. MHRA inspections and guidance shape quality management and GCP compliance practices for UK sites. Coordination with MHRA supports efficient study execution and strengthens global regulatory readiness.